Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis

Relevant markers of CSCs may serve as prognostic biomarkers of RCC. However, their actual prognostic significance remains inconclusive. Thus, a meta-analysis was performed to reevaluate the association of CSCs-relevant markers (CXCR4, CD133, CD44, CD105) expression with RCC prognosis more precisely....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncotarget 2016-10, Vol.7 (40), p.65862-65875
Hauptverfasser:	Cheng, Bo, Yang, Guosheng, Jiang, Rui, Cheng, Yong, Yang, Haifan, Pei, Lijun, Qiu, Xiaofu
Format:	Artikel
Sprache:	eng
Schlagworte:	AC133 Antigen - metabolism Biomarkers, Tumor - metabolism Carcinoma, Renal Cell - metabolism Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - pathology Humans Hyaluronan Receptors - metabolism Kidney Neoplasms - metabolism Kidney Neoplasms - mortality Kidney Neoplasms - pathology Neoplastic Stem Cells - metabolism Neoplastic Stem Cells - pathology Prognosis Receptors, CXCR4 - metabolism Research Paper Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!